Edwina Baskin-Bey
Director/Board Member bei Fight Cancer Global, Llc
Profil
Edwina S.
Baskin-Bey is currently the Executive Director at Fight Cancer Global, Llc.
Prior to this, she held positions as Director at Catalyst Clinical Research LLC, Chief Medical Officer at Nanobiotix SA, Innocrin Pharmaceuticals, Inc., and Oncternal Therapeutics, Inc. She received her undergraduate degree from Hunter College and her doctorate from New York University School of Medicine.
Aktive Positionen von Edwina Baskin-Bey
Unternehmen | Position | Beginn |
---|---|---|
Fight Cancer Global, Llc
Fight Cancer Global, Llc Information Technology ServicesTechnology Services Fight Cancer Global, LLC provides a network platform aimed at solving the isolation problems faced by cancer patients. The private company is based in Houston, TX. | Director/Board Member | - |
Ehemalige bekannte Positionen von Edwina Baskin-Bey
Unternehmen | Position | Ende |
---|---|---|
ONCTERNAL THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 17.05.2021 |
NANOBIOTIX | Chief Tech/Sci/R&D Officer | 06.04.2020 |
Innocrin Pharmaceuticals, Inc.
Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | Chief Tech/Sci/R&D Officer | - |
Catalyst Clinical Research LLC
Catalyst Clinical Research LLC BiotechnologyHealth Technology Catalyst Clinical Research LLC engages in the provision of staffing resources to the biotechnology, pharmaceutical and medical device companies. It offers augmented contract staff, monitoring teams, CRO oversight and medical writing services. The company was founded by Betsy Brown and Jean Hendrickson n 2013 and is headquartered in Durham, NC. | Director/Board Member | - |
Ausbildung von Edwina Baskin-Bey
Hunter College | Undergraduate Degree |
New York University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
NANOBIOTIX | Health Technology |
ONCTERNAL THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Catalyst Clinical Research LLC
Catalyst Clinical Research LLC BiotechnologyHealth Technology Catalyst Clinical Research LLC engages in the provision of staffing resources to the biotechnology, pharmaceutical and medical device companies. It offers augmented contract staff, monitoring teams, CRO oversight and medical writing services. The company was founded by Betsy Brown and Jean Hendrickson n 2013 and is headquartered in Durham, NC. | Health Technology |
Fight Cancer Global, Llc
Fight Cancer Global, Llc Information Technology ServicesTechnology Services Fight Cancer Global, LLC provides a network platform aimed at solving the isolation problems faced by cancer patients. The private company is based in Houston, TX. | Technology Services |
Innocrin Pharmaceuticals, Inc.
Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | Health Technology |